Ce3 Inc.'s Holly Coulter to Present at 2013 "The Inaugural Forum on Optimizing Clinical Research Performance" Conference
Guilford, CT, May 13th, 2013 – Ce3 Inc. a Clinical Contract Research Organization, today announced that its President and CEO, Holly Coulter, will present at the 2013 “The Inaugural Forum on OPTIMIZING CLINICAL RESEARCH PERFORMANCE” Conference being held at The Marriott Boston Copley Place, Boston, MA from Sunday, May 19 to Tuesday May 21, 2013.
Ms. Coulter will present a session called “Rethinking the Investigator Brochure”: A practical approach to improving communications between sponsors and investigators, using new technologies and operational knowledge to improve patient safety and overall utility of the IB.
MS. Coulter is scheduled to present on: Tuesday, May 21, 2013: 3:25 p.m. - 4:00 p.m.
For the full agenda please visit: http://www.iibig.com/conferences/P1301/agenda.html
Ce3 has provided medical writing support to the Bio-Pharma industry for the last 7 years under the leadership of our Chief Medical Officer, Dr. Deborah Church. Ce3 contributions to the approval of NDAs, INDs, Regulatory documents, Pediatric Investigation Plans (PIPs) and Clinical Study Reports (CSRs) is supported by our clients’ success and their repeated requests and referrals. We provide a team of writers and document specialists skilled in writing and quality review of these documents.
For more information about the Conference or to schedule a one-on-one meeting, please contact Ce3 Director of Business Development Mennato Forgione at 203-252-7594, email@example.com .
Ce3 is a full service contract research organization focused on providing pharmaceutical and biotechnology companies with Phase 1 – 3 clinical trial execution and regulatory submission services. Our seasoned staff works across a broad range of therapeutic areas, with particular expertise in oncology and infectious disease indications. CE3 stands for Collaborative, Experience, Efficiency & Excellence which are qualities that represent our core values and serve as the foundation for all that we do. Clients benefit from our flexibility, process efficiency, value pricing, and our collaborative relationships with state-of-the-art niche providers; a competitive edge that amplifies value in this highly regulated environment. For more information on Ce3 services, please visit www.Ce3.com and/or follow Ce3 on LinkedIn.
MassBio Membership gives you:
Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members.
Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.
MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.
Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.
Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.
Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!
Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.